Effect of retinoic acid on morphological changes of human pancreatic cancer cells on collagen gels: A possible association with the metastatic potentials

Oncology Research

Volumn 10, Issue 1, 1998, Pages 7-14

  Jimi, Sei Ichiro ^a   Shono, Tadahisa ^a   Tanaka, Masao ^a   Kono, Akira ^b   Yamada, Yuji ^c   Shudo, Koichi ^d   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Collagen gels; Metastasis; Morphological changes; Pancreatic carcinoma; Retinoic acid

Indexed keywords

BETA CATENIN; CADHERIN; COLLAGEN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN I, CELLULAR; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; TRANSACTIVATOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DNA PROBE; DRUG EFFECT; HUMAN; METABOLISM; METASTASIS; PANCREAS TUMOR; PATHOLOGY;

BETA CATENIN; CADHERINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; COLLAGEN; CYTOSKELETAL PROTEINS; DNA PROBES; HUMANS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; TRANS-ACTIVATORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031610022     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Vleminckx, K.; Vakaet, L.; Mareel, M.; Fiers, W.; Van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppresser role. Cell 66:107-119; 1991.
2. Mareel, M.; Vleminckx, K.; Vermeulen, S.; Yan, G.; Bracke, M.; van Roy, F. Downregulation in vivo of the invasion-suppresser molecule E-cadherin in experimental and clinical cancer. In: Hirohashi, S.; Moses, H. L.; Ruoslahti, E.; Sugimura, T.; Takeichi, M.; Terada, M., eds. Molecular and cellular basis for cell to cell interaction: Its significance in cancer. Proceedings of the 24th International Symposium of the Princess Takamatsu Cancer Research fund. Princeton, NJ: The Princeton Scientific Publishing Co., Inc: 1991:63-80.
3. Birchmeier, W.; Behrens, J. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198:11-26; 1994.
4. Van Roy, F. M.; Mareel, M. Tumor invasion: Effects of cell adhesion and motility. Trends Cell Biol. 2:163-166; 1992.
5. Takeichi, M. Functional correlation between cell adhesive properties and some cell surface proteins. J. Cell Biol. 75:464-174; 1977.
6. Mayer, B.; Johnson, J. P.; Leitl, F.; Jauch, K. W.; Heiss, M. M.; Schildberg, F. W.; Birchmeier, W.; Funke, I. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 53:1690-1695; 1993.
7. Nakayama, Y.; Naito, S.; Ryuto, M.; Hata, Y.; Ono, M.; Sueishi, K.; Komiyama, S.; Itoh, H.; Kuwano, M. An in vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities. Clin. Exp. Metastasis 14:466-474; 1996.
8. Nishi, Y.; Haji, M.; Takayanagi, R.; Iguchi, H.; Shimazoe, T.; Hirata, J.; Nawata, H. Establishment and characterization of PTHrP-producing human pancreatic cancer cell line. Int. J. Oncol. 5:33-39; 1994.
9. Jimi, S.; Shono, T.; Ono, M.; Kuwano, M.; Tanaka, M.; Lopez-Otin, C.; Kono, A. Expression of matrix metalloproteinases 1 and 2 genes in a possible association with metastatic abilities of human pancreatic cancer cells. Int. J. Oncol. 10:623-628; 1997.
10. Frixen, U. H.; Behrens, J.; Sachs, M.; Eberle, G.; Voss, B.; Warda, A.; Lochner, D.; Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:173-185; 1991.
11. Nakajima, M.; Lotan, D.; Baig, M. M.; Carralero, R. M.; Wood, W. R.; Hendrix, M. J. C.; Lotan, R. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 49:1698-1706; 1989.
12. Nicolson, R. C.; Mader, S.; Nagpal, S.; Leid, M.; Rochette-Egly, C.; Chambon, P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J. 9:4443-4454; 1990.
13. Marcel, M. M.; Van Roy, F. M.; Bracke, M. E. How and when do tumor cells metastasize? Crit. Rev. Oncogenesis 4:559-594; 1993.
14. Kagechika, H.; Kawachi, E.; Fukasawa, H.; Saito, G.; Iwanami, N.; Umemiya, H.; Hashimoto, Y.; Shudo, K. Inhibition of IL-1-induced IL-6 production by synthetic retinoids. Biochem. Biophys. Res. Commun. 231:243-248; 1997.
15. Umemiya, H.; Kagechika H.; Fukasawa, H.; Kawachi, E.; Ebisawa, M.; Hashimoto, Y.; Eisenmann, G.; Erb, C.; Pornon, A.; Chambon, P.; Gronemeyer, H.; Shudo, K. Action mechanism of retinoid-synergistic dibenzodiazepines. Biochem. Biophys. Res. Commun. 233:121-125; 1997.
16. Nakayama, Y.; Kohno, K.; Nomura, Y.; Naito, S.; Ono, M.; Shimizu, K.; Osato, K.; Kuwano, M. Enhanced invasive activity and decreased expression of tissue inhibitors of metalloproteinases by hepatocyte growth factor in human renal cancer cells. Cancer J. 6:213-219; 1993.
17. Ozawa, M.; Baribault, H.; Kemler, R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1711-1717; 1989.
18. Benbrook, D.; Lernhardt, E.; Pfahl, M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333:669-672; 1988.
19. Mangelsdorf, D. J.; Ong, E. S.; Dyck, J. A.; Evans, R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229; 1990.
20. Umezono, K.; Murakami, K. K.; Thompson, C. C.; Evans, R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255-1266; 1991.
21. Ishikawa, T.; Umezono, K.; Mangelsdorf, D. J.; Aburatani, H.; Stanger, B. Z.; Shibasaki, Y.; Imawari, M.; Evans, R. M.; Takaku, F. A functional retinoic acid receptor encoded by the gene on human chromosome 12. Mol. Endocrinol. 4:837-844; 1990.
22. Eller, M. S.; Oleksiak, M. F.; Mcquaid, T. J.; McAfee, S. G.; Gilchrest, B. A. The molecular cloning and expression of two CRABP cDNAs from human skin. Exp. Cell Res. 199:328-336; 1992.
23. Ryuto, M.; Jimi, S.; Ono, M.; Naito, S.; Nakayama, Y.; Yamada, Y.; Komiyama, S.; Kuwano, M. All-trans-retinoic acid-dependent inhibition of E-cadherin-based cell adhesion with concomitant dephosphorylation of β-catenin in metastatic human renal carcinoma cells. Jpn. J. Cancer Res. 88:982-991; 1997.
24. Shono, T.; Ono, M.; Izumi, H.; Jimi, S.; Matsushima, K.; Okamoto, T.; Kohno, K.; Kuwano, M. Involvement of a transcriptional factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16: 4231-4239; 1996.
25. Jimi, S.; Ito, K.; Kohno, K.; Ono, M.; Kuwano, M.; Itagaki, Y.; Ishikawa, H. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem. Biophys. Res. Commun. 211:476-483; 1995.
26. Lotan, R. Retinoids and squamous cell differentiation. In: Hong, W. K.; Lotan, R., eds. Retinoids in oncology. New York: Marcel Dekker; 1993:43-72.
27. De Luca, L. M. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5:2924-2933; 1991.
28. Bracke, M. E.; Van Larebeke, N. A.; Vyncke, B. M.; Marcel, M. M. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer 63:867-867; 1991.
29. Vermeulen, S. J.; Bruyneel, E. A.; van Roy, F. M.; Marcel, M. M.; Bracke, M. E. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br. J. Cancer 72:1447-1453; 1995.
30. Mills, K. J.; Vollberg, T. M.; Nervi, C.; Grippo, J. F.; Dawson, M. I.; Jetten, A. M. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: Effects of retinoid-receptor selective ligands. Cell Growth Differ. 7:327-337; 1996.
31. Deitrich, J. M.; McCormick, P. J. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant. Exp. Cell Res. 210: 201-208; 1994.
32. Marcel, M.; Behrens, J.; Birchmeier, W.; De Bruyne, G. K.; Vleminckx, K.; Hoogewus, A.; Fiers, W. C.; Van Roy, F. M. Down-regulation of E-cadherin expression in Madin Darby Canine Kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer 47:922-928; 1991.
33. Bracke, M. E.; Vyncke, B. M.; Bruyneel, E. A.; Vermeulen, S. J.; De Bruyne, G. K.; Van Larebeke, N. A.; Vleminckx, K.; Van Roy, F. M.; Marcel, M. M. Insulin-like growth factor I activates the invasion suppresser function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br. J. Cancer 68:282-289; 1993.
34. Munemitsu, S.; Albert, I.; Souza, B.; Rubinfeld, B.; Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppresser protein. Proc. Natl. Acad. Sci. USA 92:3046-3050; 1995.
35. Nakamura, Y. Cleaning up on β-catenin. Nature Med. 3:499-500; 1997.
36. Lotan, R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim. Biophys. Acta 605:33-91; 1980.
37. Roberts, A. B.; Sporn, M. B. Cellular biology and biochemistry of the retinoids. In: Sporn, M. B.; Roberts, A. B.; Goodman, D. S., eds. The retinoids. Vol. 2. New York: Academic Press; 1984: 209-286.
38. Leroy, P.; Krust, A.; Kastner, P.; Mendelsohn, C.; Zelent, A.; Chambon, P. Retinoic acid receptors. In: Morriss-Kay, G., ed. Retinoids in normal development and teratogenesis. New York: Oxford University Press; 1992:7-25.
39. Mangelsdorf, D.; Umesono, K.; Evans, R. M. The retinoid receptors. In: Sporn, M. B.; Roberts, A. B.; Goodman, D. S., eds. The retinoids. New York: Raven Press; 1994:319-349.
40. Boylan, J. F.; Gudas, L. J. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell. Biol. 112:965-979; 1991.
41. Boylan, J. F.; Gudas, J. L. The level of all-trans-retinoic acid metabolites in F9 teratocarcinoma cells. J. Biol. Chem. 267:21486-21491; 1991.
42. Umemiya, H.; Kawachi, E.; Kagechika, H.; Fukasawa, H.; Hashimoto, Y.; Shudo, K. Synergists for retinoid in cellular differentiation of human promyelocytic leukemia cells HL-60. Chem. Pharm. Bull. 43:1827-1829; 1995.
43. Anzano, M. A.; Byers, S. W.; Smith, J. M.; Peer, C. W.; Mullen, L. T.; Brown, C. C.; Roberts, A. B.; Sporn, M. B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with Tamoxifen. Cancer Res. 54:4614-4617; 1994.